📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations. (2021)

First Author: Tree JA

Attributed to: Advanced glycosaminoglycan sequencing funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bph.15304

PubMed Identifier: 33125711

Publication URI: http://europepmc.org/abstract/MED/33125711

Type: Journal Article/Review

Volume: 178

Parent Publication: British journal of pharmacology

Issue: 3

ISSN: 0007-1188